Mosaic ImmunoEngineering CPMV Income Statement (2010-2026)

OTC CPMV
$0.07 +0.01 (+16.67%)
At close: Aug 20, 2026 · 4:00 PM EDT
Income Statement Aug2010 Nov2010 Feb2011 May2011 Aug2011 Nov2011 Feb2012 May2012 Aug2012 Nov2012 Feb2013 May2013 Aug2013 Nov2013 Feb2014 May2014 Aug2014 Nov2014 Feb2015 May2015 Aug2015 Nov2015 Feb2016 May2016 Aug2016 Nov2016 Feb2017 May2017 Aug2017 Nov2017 Feb2018 May2018 Aug2018 Nov2018 Feb2019 May2019 Aug2019 Nov2019 Feb2020 May2020 Aug2020 Nov2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Shares Outstanding (Entity) (Quarter)
7.23M7.23M7.24M7.24M7.24M7.24M7.24M7.24M7.24M7.24M7.24M7.24M7.24M7.24M7.24M7.24M7.24M7.24M7.24M7.24M
Revenue & cost
Revenue (Quarter)
Gross Profit (Quarter)
Operating items
Amortization - Intangibles (Quarter)
Research & Development (Quarter)
0.38M0.44M0.39M0.33M0.30M0.21M0.21M0.18M0.12M0.08M0.05M0.07M0.06M0.04M0.02M0.02M0.02M0.02M0.02M0.02M
Selling, General & Administrative (Quarter)
0.53M0.52M0.43M0.40M0.58M0.31M0.29M0.28M0.23M0.23M0.23M0.20M0.21M0.15M0.13M0.16M0.13M0.13M0.13M0.14M
Restructuring Costs (Quarter)
200.000.01M
Other Operating Expenses (Quarter)
-0.95M2.66M-0.50M-0.44M-0.01M
Operating Expenses (Quarter)
0.91M0.01M3.48M0.73M0.88M0.02M0.50M0.02M0.35M0.31M0.28M0.27M0.27M0.19M0.15M0.17M0.15M0.14M0.15M0.15M
Operating Income (Quarter)
-0.96M-0.82M-0.73M-0.88M-0.52M-0.50M-0.46M-0.35M-0.31M-0.28M-0.27M-0.27M-0.19M-0.15M-0.17M-0.15M-0.14M-0.15M-0.15M
EBIT (Quarter)
-0.98M-0.96M-0.82M-0.73M-0.88M-0.52M-0.50M-0.46M-0.35M-0.31M-0.28M-0.27M-0.27M-0.19M-0.15M-0.17M-0.15M-0.14M-0.15M-0.15M
Non-operating items
Non Operating Investment Income (Quarter)
Interest & Investment Income (Quarter)
11.0012.008.007.007.0011.008.008.000.00M16.006.003.001.001.003.001.001.001.00
Other Non Operating Income (Quarter)
-0.02M500.00800.000.06M-400.000.01M0.03M0.02M0.02M0.01M
Non Operating Income (Quarter)
-0.07M-0.09M-0.03M-0.03M-0.04M0.36M-0.04M0.06M0.37M-0.02M-0.02M-0.02M-0.02M-300.00-487.00-0.01M-0.02M-0.02M-0.02M-0.02M
Net income details
EBT (Quarter)
-0.98M-1.05M-0.85M-0.76M-0.93M-0.15M-0.53M-0.40M0.02M-0.33M-0.30M-0.29M-0.29M-0.19M-0.15M-0.18M-0.17M-0.17M-0.17M-0.18M
Tax Provisions (Quarter)
0.00M0.00M0.00M0.00M
Profit After Tax (Quarter)
-0.98M-1.05M-0.85M-0.76M-0.93M-0.15M-0.53M-0.40M0.02M-0.33M-0.30M-0.29M-0.29M-0.19M-0.15M-0.18M-0.17M-0.17M-0.17M-0.18M
Equity Income (Quarter)
Income from Continuing Operations (Quarter)
-0.98M-1.05M-0.85M-0.76M-0.93M-0.15M-0.53M-0.40M0.02M-0.33M-0.30M-0.29M-0.29M-0.19M-0.15M-0.18M-0.17M-0.17M-0.17M-0.18M
Consolidated Net Income (Quarter)
-0.98M-1.05M-0.85M-0.76M-0.93M-0.15M-0.53M-0.40M0.02M-0.33M-0.30M-0.29M-0.29M-0.19M-0.15M-0.18M-0.17M-0.17M-0.17M-0.18M
Income towards Parent Company (Quarter)
-0.98M-1.05M-0.85M-0.76M-0.93M-0.15M-0.53M-0.40M0.02M-0.33M-0.30M-0.29M-0.29M-0.19M-0.15M-0.18M-0.17M-0.17M-0.17M-0.18M
Net Income towards Common Stockholders (Quarter)
-0.98M-1.05M-0.85M-0.76M-0.93M-0.15M-0.53M-0.40M0.02M-0.33M-0.30M-0.29M-0.29M-0.19M-0.15M-0.18M-0.17M-0.17M-0.17M-0.18M
Additional items
EPS (Basic) (Quarter)
-0.14-0.15-0.13-0.11-0.13-0.02-0.07-0.060.00-0.05-0.04-0.04-0.04-0.03-0.02-0.03-0.02-0.02-0.02-0.02
EPS (Diluted) (Quarter)
-0.14-0.15-0.13-0.11-0.13-0.02-0.07-0.060.00-0.05-0.04-0.04-0.04-0.03-0.02-0.03-0.02-0.02-0.02-0.02
Shares Outstanding (Quarter)
7.22M7.22M6.71M7.24M7.24M7.24M7.24M7.24M7.24M7.24M7.24M7.24M7.24M7.24M7.24M7.24M7.24M7.24M7.24M7.24M
Shares Outstanding (Diluted) (Quarter)
7.22M7.22M6.71M7.24M7.24M7.24M7.24M7.24M8.57M7.24M7.24M7.24M7.24M7.24M7.24M7.24M7.24M7.24M7.24M7.24M
EBITDA (Quarter)
-0.98M-0.96M-0.82M-0.73M-0.88M-0.52M-0.50M-0.46M-0.35M-0.31M-0.28M-0.27M-0.27M-0.19M-0.15M-0.17M-0.15M-0.14M-0.15M-0.15M
Interest Expenses (Quarter)
0.00M0.01M0.00M0.00M0.00M0.00M
Tax Rate (Quarter)
-0.26-0.61-1.59-1.41